30.09.2016 • NewsCatalentElaine BurridgeLonza

Catalent to Acquire Pharmatek Laboratories

(c) Catalent
(c) Catalent

Catalent has announced plans to acquire Pharmatek Laboratories, a contract drug development and clinical manufacturing company, for an all-cash undisclosed sum. The acquisition will add extensive early-phase drug development capabilities from discovery to clinic, bring spray drying into Catalent’s portfolio of drug formulation and delivery technologies and expand the New Jersey-based firm’s capability for handling highly potent compounds. Pharmatek provides dosage form development and clinical-scale cGMP manufacturing of oral, injectable and topical products, as well as its own drug development platform.

Barry Littlejohns, president of Catalent’s Drug Delivery Solutions business, said the addition of Pharmatek will create an unparalleled drug development platform, and its facility in San Diego, California, will expand its presence on the US west coast and provide additional access to markets in Asia-Pacific. The San Diego site comprises two analytical laboratories, two formulation laboratories, four engineering rooms and nine certified ISO Class 8 suites, as well as laboratory, manufacturing and support space for developing and manufacturing highly potent compounds.

Completion of the transaction is expected to take place in the next few weeks, subject to the usual closing conditions. The deal is seen as an about-face for Catalent, which was rumored in April to be a takeover target for Swiss group Lonza.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.

most read

Photo
22.04.2025 • News

BASF Divests Two Joint Ventures in China

BASF has divested its shares in the joint venture companies, BASF Markor Chemical Manufacturing (Xinjiang) Co., Ltd. and Markor Meiou Chemical (Xinjiang) Co., Ltd. in Korla, China, to Verde Chemical Singapore Pte. Ltd.

Photo
28.07.2025 • NewsChemistry

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.

Photo
13.03.2025 • News

Roche and Zealand Pharma Collaborate on Weight Management Drug

Swiss pharma heavyweight Roche announced has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma. Under the terms of this agreement, the two companies will collaborate to co-develop and co-commercialize petrelintide, Zealand Pharma’s amylin analog as a standalone therapy as well as a fixed-dose combination with Roche’s lead incretin asset CT-388.